A team from Harvard Medical School unveiled an AI tool capable of accurately distinguishing glioblastoma from other visually similar brain tumors intraoperatively. This real-time diagnostic innovation promises to improve surgical decision-making, enabling tailored interventions and potentially enhancing patient outcomes in aggressive brain cancers known for diagnostic challenges.